臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"ann lii cheng"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 266-290 / 690 (共28頁)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-09-01T01:54:11Z	Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma	Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; Kuo S.-H.; Hsu C.-H.; Lu Y.-S.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:11Z	CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells	Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; Liu T.-H.; Hou D.-R.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:10Z	Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma	Shao Y.U.-Y.; Chen P.-J.; Lin Z.-Z.; Huang C.-C.; Ding Y.-H.; Lee Y.-H.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:10Z	Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A	Chen K.-F.; Yu H.-C.; Liu C.-Y.; Chen H.-J.; Chen Y.-C.; Hou D.-R.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:10Z	Needs for hepatocellular carcinoma control policy in the Asia-Pacific region	Bridges J.F.P.; Joy S..; Gallego G.; Kudo M.; Ye S.-L.; Han K.-H.; ANN-LII CHENG; Blauvelt B.
臺大學術典藏	2021-09-01T01:54:10Z	Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf	Chen K.-F.; Tai W.-T.; Huang J.-W.; Hsu C.-Y.; Chen W.-L.; ANN-LII CHENG; Chen P.-J.; Shiau C.-W.
臺大學術典藏	2021-09-01T01:54:10Z	Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells	Chen K.-F.; Chen H.-L.; Tai W.-T.; Feng W.-C.; Hsu C.-H.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:09Z	Phase I, pharmacokinetic, and bone marrow drug-level studies of trimonthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers	Ho Y.-F.; Lu W.-C.; Chen R.R.-L.; ANN-LII CHENG; Yeh K.-H.
臺大學術典藏	2021-09-01T01:54:09Z	Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma	Tai W.-T.; ANN-LII CHENG; Shiau C.-W.; Huang H.-P.; Huang J.-W.; Chen P.-J.; Chen K.-F.
臺大學術典藏	2021-09-01T01:54:09Z	Increasing incidence of brain metastasis in patients with advanced Hepatocellular carcinoma in the era of Antiangiogenic targeted therapy	Shao Y.-Y.; Lu L.-C.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-09-01T01:54:08Z	A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan	Chen J.-S.; Chao Y.; Hsieh R.-K.; ANN-LII CHENG; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; Yeh K.-H.; Chen L.-T.; Whang-Peng J.
臺大學術典藏	2021-09-01T01:54:08Z	Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells	Rodriguez B.A.T.; Weng Y.-I.; Liu T.-M.; Zuo T.; Hsu P.-Y.; Lin C.-H.; ANN-LII CHENG; Cui H.; Yan P.S.; Huang T.H.-M.
臺大學術典藏	2021-09-01T01:54:08Z	IκB kinases increase Myc protein stability and enhance progression of breast cancer cells	Yeh P.-Y.; Lu Y.-S.; Ou D.-L.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:08Z	Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001	Kuo S.-H.; Hsu C.-H.; Chen L.-T.; Lu Y.-S.; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:07Z	Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients?	Lin C.-H.; Lu Y.-S.; Huang C.-S.; Kuo K.-T.; Wang C.-C.; You S.-L.; Lin P.-H.; Chang D.-Y.; Kuo W.-H.; Chang K.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:07Z	Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib	Harmon C.S.; DePrimo S.E.; Raymond E.; ANN-LII CHENG; Boucher E.; Douillard J.-Y.; Lim H.Y.; Kim J.S.; Lechuga M.J.; Lanzalone S.; Lin X.; Faivre S.
臺大學術典藏	2021-09-01T01:54:07Z	Changes in tumor density in patients with advanced hepatocellular carcinoma treated with sunitinib	Faivre S.; Zappa M.; Vilgrain V.; Boucher E.; Douillard J.-Y.; Lim H.Y.; Kim J.S.; Im S.-A.; Kang Y.-K.; Bouattour M.; Dokmak S.; Dreyer C.; Sablin M.-P.; Serrate C.; ANN-LII CHENG; Lanzalone S.; Lin X.; Lechuga M.J.; Raymond E.
臺大學術典藏	2021-09-01T01:54:06Z	High circulating endothelial progenitor levels associated with poor survival of advanced hepatocellular carcinoma patients receiving sorafenib combined with metronomic chemotherapy	Shao Y.-Y.; Lin Z.-Z.; Chen T.-J.; Hsu C.; Shen Y.-C.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:06Z	Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil	Hsu C.-Y.; Shen Y.-C.; Yu C.-W.; Hsu C.; Hu F.-C.; Hsu C.-H.; Chen B.-B.; Wei S.-Y.; ANN-LII CHENG; Shih T.T.-F.
臺大學術典藏	2021-09-01T01:54:06Z	Establishment of a novel MALT lymphoma cell line, ma-1, from a patient with t(14;18)(q32;q21)-positive Helicobacter Pylori-independent gastric MALT lymphoma	Kuo S.-H.; Weng W.-H.; Chen Z.-H.; Hsu P.-N.; Wu M.-S.; Lin C.-W.; Jeng H.-J.; Yeh K.-H.; Tsai H.-J.; Chen L.-T.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:05Z	Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study	Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T.
臺大學術典藏	2021-09-01T01:54:05Z	Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era	Chen I.C.; Lin C.H.; Huang C.S.; Lien H.C.; Hsu C.; Kuo W.H.; Lu Y.S.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:05Z	Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials	Yang S.-H.; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:04Z	Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells	Lin Y.-C.; Wu M.-H.; Wei T.-T.; Chung S.-H.; Chen K.-F.; ANN-LII CHENG; Chen C.-C.
臺大學術典藏	2021-09-01T01:54:04Z	Antiangiogenic strategies for the treatment of hepatocellular carcinoma	Hsu C.; Shen Y.-C.; ANN-LII CHENG

顯示項目 266-290 / 690 (共28頁)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51190168 線上人數 : 770 教育部委託研究計畫計畫執行:國立臺灣大學圖書館